During the past decade, Northside Hospital Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 31 clinical trials were completed, i.e. on average, 442.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northside Hospital Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Eastern Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital Cancer Center" are "Breast Cancer" (17 trials), "Lung Cancer" (10 trials), "Lymphoma" (7 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Northside Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Northside Hospital Cancer Center" are "Drug" (41 trials), "Other" (19 trials), "Biological" (13 trials), "Radiation" (13 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "placebo" (7 trials), "bevacizumab" (6 trials), "biologic sample preservation procedure" (5 trials) and "prednisone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital Cancer Center" are 44 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Northside Hospital Cancer Center". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Northside Hospital Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital Cancer Center, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".